About Elutia, Inc. 
Elutia, Inc.
Pharmaceuticals & Biotechnology
Aziyo Biologics, Inc. is a commercial-stage regenerative medicine company. The Company is focused on the development of products for patients undergoing surgery, concentrating on patients receiving implantable medical devices. Its products are designed to address the implantable electronic device/cardiovascular, orthopedic/spinal repair and soft tissue reconstruction markets. The Company's products include CanGaroo, ProxiCor, Tyke, VasCure, FiberCel, ViBone, OsteGro V and SimpliDerm. The Company fulfill tissue processing contracts through its contract manufacturing services at its Richmond, California facility.
Company Coordinates 
Company Details
12510 PROSPERITY DRIVE, SUITE 370 , SILVER SPRING MD : 20904
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 5 Schemes (3.69%)
Foreign Institutions
Held by 8 Foreign Institutions (0.2%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Kevin Rakin
Chairman of the Board
Mr. Ron Lloyd
President, Chief Executive Officer, Director
Revenue and Profits:
Net Sales:
6 Million
(Quarterly Results - Jun 2025)
Net Profit:
-10 Million
Pharmaceuticals & Biotechnology
USD 80 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.62
67.24%
-1.90






